Singapore, Nov. 17 -- South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and precision oncology, and US-based Labcorp, a global leader of innovative and comprehensive laboratory services, have announced a collaborative initiative to accelerate innovation in digital pathology (DP) and artificial intelligence (AI) for oncology research and clinical care.

The collaboration aims to leverage Labcorp's extensive clinical and pathology expertise alongside Lunit's cutting-edge AI algorithms to transform how tumour microenvironments are analyzed and interpreted.

By combining high-resolution whole-slide imaging with AI-powered spatial profiling, the collaboration seeks to generate new insights that ...